Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CA Stock MarketDetailed Quotes
Cosciens Biopharma Inc (CSCI)
- 2.800
- +0.080+2.94%
15min DelayMarket Closed Apr 17 16:00 ET
8.92MMarket Cap-0.62P/E (TTM)
2.800High2.730Low1.91KVolume2.800Open2.720Prev Close5.32KTurnover6.00052wk High0.06%Turnover Ratio3.18MShares1.10052wk Low-4.488EPS TTM8.87MFloat Cap9.000Historical HighLossP/E (Static)3.17MShs Float1.100Historical Low-4.488EPS LYR2.57%Range %--Dividend TTM1.69P/B1Lot Size--Div Yield TTM
Cosciens Biopharma Inc (CSCI) Cash Flow
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 41.84%-8.47M | 50.98%-1.47M | 91.31%-676K | -220.16%-4.45M | 21.01%-1.88M | -464.21%-14.57M | -176.41%-3M | -5,502.08%-7.78M | -70.85%-1.39M | -187.10%-2.38M |
| Net income from continuing operations | 32.34%-10.36M | 67.57%-2.18M | 68.39%-1.82M | -89.94%-2.7M | -160.89%-3.66M | -339.28%-15.31M | -330.37%-6.73M | -641.62%-5.76M | -65.35%-1.42M | -392.14%-1.4M |
| Operating gains losses | 101.95%45K | 76.43%-107K | -202.94%-412K | 126.17%448K | --116K | ---2.3M | ---454K | ---136K | ---1.71M | ---- |
| Depreciation and amortization | -26.07%1.19M | -26.28%289K | -40.08%287K | -23.87%287K | -9.47%325K | 11.37%1.61M | 9.19%392K | 31.96%479K | 4.14%377K | 0.07%359K |
| Asset impairment expenditure | -92.58%316K | --0 | -78.34%316K | ---- | ---- | --4.26M | --2.8M | --1.46M | ---- | ---- |
| Remuneration paid in stock | -102.59%-12K | 780.00%88K | -104.92%-21K | -753.85%-85K | -57.14%6K | 141.67%464K | -37.50%10K | 1,193.94%427K | -69.77%13K | -85.88%14K |
| Deferred tax | -87.34%10K | -99.07%10K | --0 | --0 | --0 | 108.93%79K | 399.17%1.08M | 47.17%-112K | -101.70%-474K | -428.98%-412K |
| Other non cashItems | 105.41%46K | 99.29%-6K | 237.50%22K | 163.64%29K | -95.24%1K | -994.74%-850K | ---845K | ---16K | --11K | -15.96%21K |
| Change In working capital | 111.61%292K | -41.78%439K | 123.05%951K | -233.39%-2.43M | 238.09%1.33M | -4,434.48%-2.51M | 104.34%754K | -660.46%-4.13M | 1,578.05%1.82M | -3.97%-961K |
| -Change in receivables | ---- | ---- | 274.74%1.71M | -242.15%-607K | 286.79%1.34M | ---- | ---- | -327.97%-978K | -56.74%427K | -1,107.36%-719K |
| -Change in inventory | ---- | ---- | 71.36%-59K | 53.09%767K | ---- | ---- | ---- | -21.89%-206K | 174.44%501K | 208.67%392.46K |
| -Change in prepaid assets | ---- | ---- | 119.17%583K | -161.14%-225K | 232.50%159K | ---- | ---- | 424.39%266K | 621.57%368K | -371.88%-120K |
| -Change in payables and accrued expense | ---- | ---- | 74.00%-927K | -487.26%-2.19M | 295.08%238K | ---- | ---- | -739.07%-3.57M | 215.78%565K | 74.49%-122K |
| -Change in other working capital | ---- | ---- | -198.89%-355K | -300.00%-172K | ---413K | ---- | ---- | --359K | ---43K | ---- |
| Interest paid (cash flow from operating activities) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 12.87%-21.77K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 41.84%-8.47M | 50.98%-1.47M | 91.31%-676K | -220.16%-4.45M | 21.01%-1.88M | -464.21%-14.57M | -176.41%-3M | -5,502.08%-7.78M | -70.85%-1.39M | -187.10%-2.38M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -101.83%-458K | 163.61%201K | -95.18%4K | -100.19%-48K | -9.04%-615K | 3,536.03%25.08M | 46.89%-316K | 266.00%83K | 48,025.93%25.88M | -1,713.67%-564K |
| Net PPE purchase and sale | 60.21%-462K | 162.46%193K | 103.05%4K | 69.43%-48K | -8.33%-611K | -60.80%-1.16M | 47.36%-309K | -162.00%-131K | -190.74%-157K | -1,713.67%-564K |
| Net business purchase and sale | --0 | --0 | --0 | --0 | ---- | --26.04M | --0 | --0 | --26.04M | ---- |
| Net other investing changes | -98.07%4K | 214.29%8K | ---- | ---- | ---4K | 2,687.50%207K | ---7K | --214K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -101.83%-458K | 163.61%201K | -95.18%4K | -100.19%-48K | -9.04%-615K | 3,536.03%25.08M | 46.89%-316K | 266.00%83K | 48,025.93%25.88M | -1,713.67%-564K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 30.78%-407K | 92.57%-15K | 54.79%-85K | 15.08%-107K | -112.77%-200K | -64.71%-588K | -22.42%-202K | -218.64%-188K | -80.00%-126K | -51.02%-94K |
| Net issuance payments of debt | 13.30%-365K | 86.24%-15K | 25.44%-85K | 48.41%-65K | -112.77%-200K | -13.78%-421K | 33.94%-109K | -60.56%-114K | -80.00%-126K | -47.52%-94K |
| Proceeds from stock option exercised by employees | 74.85%-42K | ---- | ---- | ---- | ---- | -1,384.62%-167K | ---93K | -716.67%-74K | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---42K | ---- | ---- | ---- | ---74K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 30.78%-407K | 92.57%-15K | 54.79%-85K | 15.08%-107K | -112.77%-200K | -64.71%-588K | -22.42%-202K | -218.64%-188K | -80.00%-126K | -51.02%-94K |
| Net cash flow | ||||||||||
| Beginning cash position | 145.48%16.39M | -57.38%8.52M | -66.43%9.33M | 292.41%13.76M | 145.48%16.39M | -34.47%6.68M | 139.10%20M | 225.65%27.8M | -62.28%3.51M | -34.60%6.68M |
| Current changes in cash | -194.07%-9.34M | 63.49%-1.28M | 90.40%-757K | -118.89%-4.6M | 11.29%-2.7M | 370.56%9.93M | -90.62%-3.52M | -22,625.71%-7.88M | 2,700.32%24.37M | -229.39%-3.04M |
| Effect of exchange rate changes | 218.87%252K | 176.14%67K | -166.67%-52K | 364.18%177K | 144.78%60K | -235.03%-212K | -155.35%-88K | 137.32%78K | -137.22%-67K | ---134K |
| End cash Position | -55.43%7.31M | -55.43%7.31M | -57.38%8.52M | -66.43%9.33M | 292.41%13.76M | 145.48%16.39M | 145.48%16.39M | 139.10%20M | 225.65%27.8M | -62.25%3.51M |
| Free cash from | 41.64%-9.18M | 54.17%-1.52M | 91.45%-676K | -190.82%-4.5M | 15.25%-2.5M | -376.06%-15.73M | -97.85%-3.31M | -8,514.89%-7.91M | -78.32%-1.55M | -242.29%-2.94M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm